This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Child drug trial safety test call
New prescription charges campaign
Extra funds to fight superbugs
Mesalazine approved for ulcerative colitis
Health data publisher acquires intelligence firm
Wyeth’s ex-CEO received $20m in 2007
Pharmacy chain moves into worksite centres
Trabectedin (Yondelis®; ET-743): a drug of marine origin for soft-tissue sarcomas
Sorafenib and hepatocellular carcinoma
EU health and the law – or, is garlic a medicine?
Beware the illusion of communication
Stick to current clopidogrel regimen, say researchers
« Previous
1
…
209
210
211
212
213
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: